Navigation Links
SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT
Date:4/23/2008

IRVINE, Calif., April 23 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles and opinions on the subject and sector.

Investors can view SectorWatch.biz MarketStats by visiting: http://www.SectorWatch.biz -- a division of financial news hub SmallCapSentinel.com

Today's MarketStats on diagnostic companies include: Kraig Biocraft Laboratories, Inc. (OTC Bulletin Board: KBLB), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Bio-Reference Laboratories Inc. (NasdaqGS: BRLI) and Abbott Laboratories (NYSE: ABT).

To view a complete StockUpTicks.com profile on Kraig Biocraft Laboratories, Inc. visit http://stockupticks.com/profiles/3-10-08.html

Visit SectorWatch's parent site SmallCapSentinel.com for a Biotechnology message board and to read or contribute articles on the subject. Users are invited to post editorials and messages on the website. Intelligent articles submitted through the site will be posted as Member Editorials for review by the investing public. http://smallcapsentinel.com/stock/healthcare-biotechnology/biotechnology%3A - research-therapeutics-discovery (Please copy and paste into your web browser)

MarketStats provide snapshots and analysis on public equities making news, driving industry sectors and affecting the markets. SectorWatch.biz is powered by Market Pathways, a leader in the representation of Small Cap equities for over twenty-five years and your discovery zone for under-followed stocks emerging in the market.

Interested investors may subscribe to our StockUpTicks newsletter featuring a treasure trove of promising companies, daily market movers and free personal investment information -- visit http://stockupticks.com/register.html. D.R. Clark of Market Pathways is a member of the National Association of Securities Dealers, CRD # 4518163.

Contact us directly to have your company featured in StockUpTicks.com or SectorWatch.biz. For D.R. Clark's perspective on personal finance and the markets visit http://www.ClarkReport.com

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SectorWatch.biz and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies have not always approved the statements made in this report.

This report is neither a solicitation to buy nor an offer to sell securities but is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor, analyst or licensed broker dealer and this report is not investment advice. MP has been paid thirty thousand dollars by Kraig Biocraft Laboratories, Inc. for preparation and distribution of this report and other services over a ninety day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company.


'/>"/>
SOURCE SectorWatch.biz
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
2. Pharmos Issues Letter to Shareholders
3. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
4. HHS Issues First Department-Wide Report on Personalized Health Care
5. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
6. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
7. CCPM Issues Statement on FDAs GIVE Initiative
8. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
9. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... New Orleans, La. (PRWEB) , ... ... ... Polymer Monitoring Technologies today announced a comprehensive rebrand and a name change ... products for the industrial and laboratory monitoring of polymer and biopharmaceutical manufacturing ...
(Date:4/26/2017)... ... April 26, 2017 , ... Looking for gift ideas for ... company, offers one-of-a-kind gifts, ranging from gourmet cooking experiences to Farmer’s Market Tours ... leave inspired with new cooking tips and techniques, thanks to Chef Jodi Abel’s ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... EMEA and North America this May on the following ... , Donald H. Taylor, Chairman of the Learning and Performance Institute will be ...
(Date:4/25/2017)... Diego, CA (PRWEB) , ... April 25, 2017 ... ... division of L3 Healthcare, is pleased to announce the company is now a ... management. The iMedNet software certification enables the company’s clinical research team to ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):